Deregulated Mitochondrial DNA in Diseases.

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• Mitochondria are vital for cellular energy, metabolism, and apoptosis.
• Mitochondrial DNA (mtDNA) alterations, including mutations and copy number variations, are linked to cancer and diseases.
• Specific mtDNA mutations (D-loop, MT-ND1, MT-ND5, MT-TL1) are implicated in various cancers and neuromuscular disorders.

Purpose of the Study:

• To review the role of mitochondrial dysfunction in diseases, particularly cancer.
• To discuss the therapeutic potential of targeting mtDNA alterations and mitochondrial dysfunction.
• To highlight mtDNA mutations as potential biomarkers for prognosis and drug resistance.

Main Methods:

• Literature review of studies on mitochondrial dysfunction and mtDNA alterations.
• Analysis of the link between specific mtDNA mutations and disease pathologies.
• Evaluation of current and emerging mitochondria-targeted therapies.

Main Results:

• Mitochondrial dysfunction, driven by mtDNA alterations, is a key factor in cancer and disease progression.
• mtDNA repair enzymes represent a therapeutic target to inhibit cancer metastasis.
• Certain mtDNA mutations can predict drug resistance and patient prognosis.

Conclusions:

• mtDNA alterations are significant contributors to various pathologies, presenting therapeutic opportunities.
• Mitochondria-targeted therapies, including mtDNA repair and mitochondrial transplantation, show promise.
• mtDNA mutations serve as valuable biomarkers for disease prognosis and treatment response.